Thromboembolism and Bleeding Risks in Atrial Fibrillation: Outcomes of Oral Anticoagulation After Catheter Ablation
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.047527 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Lan Ren und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases Beijin…. Hauptthemen laut MEDLINE: Anticoagulants, Atrial Fibrillation, Catheter Ablation, Hemorrhage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Despite the growing use of catheter ablation for atrial fibrillation, large‐scale studies assessing the efficacy and safety of oral anticoagulation (OAC) after ablation, particularly in patients with high stroke risk, remain limited.
Methods
This prospective study enrolled consecutive patients from the China‐AF (China Atrial Fibrillation) registry between August 2011 and June 2022. Stroke risk was stratified by CHA 2 DS 2 ‐VA score as low (0–1), intermediate (2), or high (≥3). The study end points were thromboembolism (ischemic stroke or systemic embolism), and bleeding (International Society on Thrombosis and Hemostasis major bleeding and clinically relevant non‐major bleeding). A 6‐month landmark analysis was applied to evaluate the association of OAC with end points using incidence rates and Cox models.
Results
Among 13 669 patients (median follow‐up, 4.0 years), 2637 continued and 11 032 discontinued OAC at the 6‐month landmark. OAC was not associated with reduced thromboembolism risk across low‐ (adjusted hazard ratio [aHR], 1.11 [95% CI, 0.70–1.77]; P =0.649), intermediate‐ (aHR, 0.64 [95% CI, 0.36–1.16]; P =0.141) or high‐stroke risk patients (aHR, 1.05 [95% CI, 0.74–1.48]; P =0.801). In contrast, continued OAC was associated with higher bleeding risk, including clinically relevant non‐major bleeding across stroke risk strata, and International Society on Thrombosis and Hemostasis major bleeding among high‐risk patients (aHR, 2.32 [95% CI, 1.19–4.50]; P =0.013). These results were consistent across subgroups and sensitivity analyses.
Conclusions
In this large, real‐world cohort of patients with atrial fibrillation undergoing catheter ablation, continued OAC was not associated with lower thromboembolic risk, but with higher major bleeding risk among patients with CHA 2 DS 2 ‐VA scores ≥3. These findings support individualized post‐ablation anticoagulation strategies and warrant future investigation. Registration URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT06987825.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases Beijing China.
ORCID-Profile: Xiaodong Peng, Sitong Li, Jue Wang, Jingrui Zhang, Yiwei Lai, Shijun Xia, Jingye Li, Zhen Wang, Zixu Zhao, Zejun Yang, Mingxiao Li, Song Zuo, Songnan Li, Ribo Tang, Deyong Long, Xin Du, Jianzheng Dong, Caihua Sang, Changsheng Ma
Zitieren
APA
Ren, L., Peng, X., Li, S., Wang, J., Zhang, J., Lai, Y., Xia, S., Li, J., Wang, Z., Hu, G., Li, Q., Zhou, L., Zhao, Z., Yang, Z., Li, M., Liu, X., Guo, X., Zuo, S., Li, S., …, & Ma, C. (2026). Thromboembolism and Bleeding Risks in Atrial Fibrillation: Outcomes of Oral Anticoagulation After Catheter Ablation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.047527
Vancouver
Ren L, Peng X, Li S, Wang J, Zhang J, Lai Y, et al. Thromboembolism and Bleeding Risks in Atrial Fibrillation: Outcomes of Oral Anticoagulation After Catheter Ablation. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.047527
BibTeX
@article{Ren2026,
author = {Ren, Lan and Peng, Xiaodong and Li, Sitong and Wang, Jue and Zhang, Jingrui and Lai, Yiwei and Xia, Shijun and Li, Jingye and Wang, Zhen and Hu, Gaifeng and Li, Qifan and Zhou, Le and Zhao, Zixu and Yang, Zejun and Li, Mingxiao and Liu, Xiaoxia and Guo, Xueyuan and Zuo, Song and Li, Songnan and Zhou, Ning and Tang, Ribo and Long, Deyong and He, Liu and Du, Xin and Dong, Jianzheng and Sang, Caihua and Ma, Changsheng},
title = {Thromboembolism and Bleeding Risks in Atrial Fibrillation: Outcomes of Oral Anticoagulation After Catheter Ablation},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.047527}
}
EUVIMED